2 results match your criteria: "Fondazione IRCCS S. Matteo Hospital[Affiliation]"

Article Synopsis
  • Remdesivir, approved for COVID-19 treatment, was analyzed in a study comparing its effects over 5 vs. 10 days against standard treatment in hospitalized patients.
  • The study found that patients treated with remdesivir had a higher clinical recovery rate at 14 days (65.2% vs 57.1%) and a lower mortality rate at 28 days (12.0% vs 16.2%) compared to those receiving standard care.
  • These findings suggest that remdesivir significantly enhances recovery and reduces mortality in patients hospitalized with COVID-19.
View Article and Find Full Text PDF

Aim: We sought to verify which changes in right ventricular pressures occur before acute heart failure (HF) in patients with advanced systolic left ventricular (LV) dysfunction. In patients with chronic HF, continuous hemodynamic monitoring by implantable devices may detect increases in pulmonary pressures before the onset of symptoms.

Methods: A device which allowed monitoring of right ventricular systolic (RVSP) and diastolic pressure (RVDP) and an estimate of pulmonary artery diastolic pressure (ePAD) was implanted in 10 patients with advanced LV systolic dysfunction and frequent cardiovascular hospitalizations [mean age 56.

View Article and Find Full Text PDF